Moving off the critical path: Streamlining strategies for drug substance synthesis and manufacturing
Richard Castledine talks to Pharmaceutical Technology about moving off the critical path and streamlining strategies for drug substance synthesis and manufacturing
Pharmaceutical Technology interview with Paul Quigley, Head of Production, Drug Substance on timeline acceleration with drug substance and drug product
Paul Quigley, Head of Production, Drug Substance at Quotient Sciences, was featured in a interview with Pharmaceutical Technology regarding the acceleration of development timelines between drug substance and drug product.
Quotient Sciences Announces Multimillion-Pound Investment in Drug Substance Manufacturing Facility
Quotient Sciences, the drug development and manufacturing accelerator, announced a £6.3 million-pound investment in its recently acquired manufacturing facility in Alnwick, U.K. The investment will significantly expand Quotient’s drug substance manufacturing capability and will create 80 new jobs over the next three years.